NNNN — Anbio Biotechnology

Nasdaq · Health Care · Life Sciences Tools & Services · CIK 1982708 ·
Last close
$33.01
Market Cap
$1.45B
52W High
$35.50
52W Low
$20.10
ADV30
25,527
Next earnings
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 30,242,859 7,766,738 87,836
Jun 2025 27,680,594 5,348,490 131,127
Dec 2024 18,921,784 11,760,859 1,730,234

Balance + Analyst (yfinance extras)

Retained Earnings
$23,577,004
Inventory
Receivables
$3,656,912
ST Investments
$4,134,493
EBIT TTM
Pretax Income TTM
Interest Exp TTM
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$8,646,844
EBITDA
Free Cash Flow
$-9,605,703
Enterprise Value
$1,415,440,640
Total Cash
$11,901,231
Total Debt
$0
Shares Out
43,891,200
Trailing EPS
$0.14
Book Value
$0.69
ROE
27.0%
ROA
14.7%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 8,646,844 5,767,740 6,403,463 30,242,859 87,836 -6,739,075
Dec 2024 8,185,146 1,995,367 2,372,842 18,921,784 1,730,234 2,080,387
Dec 2023 6,711,990 1,960,929 2,253,709 15,811,768 993,060 898,367
Dec 2022 23,544,652 10,195,588 10,011,177 13,958,275 1,411,285 4,448,846

Peers — same industry

TickerNameMarket CapLastDaily %
NTLA Intellia Therapeutics, Inc. $1.76B $12.61
NEOG NEOGEN CORP $1.99B $9.14
CLDX Celldex Therapeutics, Inc. $2.42B $30.85
ABSI Absci Corp $823.18M $5.28
QDEL QuidelOrtho Corp $817.61M $11.99

News headlines (Yahoo Finance, 1h cache)

Discovering US Undiscovered Gems In May 2026
2026-05-21 17:33 · Yahoo
Undiscovered Gems in the US Market May 2026
2026-05-21 11:33 · Yahoo
US Undiscovered Gems to Watch in May 2026
2026-05-19 11:33 · Yahoo
Uncovering 3 Undiscovered Gems in the US Market
2026-05-18 11:33 · Yahoo
Discovering Hidden Opportunities in US Stocks with Strong Potential
2026-05-15 17:33 · Yahoo
Discovering US Market's Undiscovered Gems in May 2026
2026-05-07 17:33 · Yahoo
Undiscovered Gems in the US Market for May 2026
2026-05-07 11:33 · Yahoo
Undiscovered Gems In The US Market Featuring 3 Promising Small Caps
2026-05-06 17:33 · Yahoo
3 Undiscovered Gems In The US Market To Watch
2026-04-29 17:33 · Yahoo
Unveiling 3 Undiscovered Gems in the US Market
2026-04-28 17:33 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.